主页 > 医学前沿 >

【技术产业】苏格兰ITI Life Sciences致力于发展分子

苏格兰ITI Life Sciences致力于发展分子影像技术

关于苏格兰科技中介中心(Intermediary Technology Institutes)
苏格兰科技中介中心系由当地的经济发展机构─苏格兰工商委员会于2003年成立,十年内将投注4亿5千万英镑(约新台币265亿5千万),发展前瞻科技产业。科技中介中心目前规划为能源(ITI Energy)、生命科学(ITI Life Science)和通讯/数字媒体科技(ITI Techmedia)研究院等。主要目的负责扶植与鼓励创新,并将专业知识转化为新兴企业甚或跨国公司。具体如下
·支持苏格兰企业研发,涵盖全球主要市场。
·协助苏格兰成为全球知名的专业科技中心,提升企业的全球竞争力。
·长期而言,大幅增加苏格兰境内的高成长科技中心。
科技中介中心将扮演「店面(shop front)」的角色,将其益处及优点宣扬到整个苏格兰地区。研发活动将委托相关大学、公司、或研究机构来进行,而研发活动的商业化将催生许多新兴企业与机构。不仅如此,英国各地均有机会因其蓬勃发展而受益。更多信息可上网至www.itiscotland.com 查询。

Call for Expressions of Interest
ITI Life Sciences Seeks to Fund Innovation in Molecular Imaging
DUNDEE, Scotland, Oct. 12, 2006 (PRIMEZONE) -- ITI Life Sciences, the organisation set up by Scottish Enterprise as an "innovation fund" to leverage Scotland's excellence in early stage life sciences research, today issues a Call for Expressions of Interest from organisations or individuals with expertise in the field of Molecular Medical Imaging. Based on an in-depth market analysis ("foresighting") report published earlier this year, ITI Life Sciences (ITI LS) has identified this area as one with significant potential and is seeking to explore opportunities for funding an innovative R&D programme.


While medical imaging is already firmly established as an integral part of modern healthcare, molecular imaging offers an exciting and altogether more powerful perspective -- the ability to go beyond visualising anatomy and physiology to study metabolic and physiological processes, often in real time. As such it promises to have a huge impact both on the practice of medicine and the development of new therapeutics and diagnostics over the coming decade.

Eleanor Mitchell, Acting CEO of ITI Life Sciences says: "ITI Life Sciences believes there are numerous opportunities within the molecular imaging field and a compelling case for funding innovation within this field. We would therefore like to engage with appropriate individuals and/or organisations to identify exciting R&D opportunities that may form the basis of an ITI LS funded programme."

Over the past two years ITI LS has committed over GBP42 million ($82 million) from its "innovation fund" to R&D programmes ranging from biomarkers and point-of-care diagnostics to text mining.

The ITI team has a good track record of working with entrepreneurial companies and is skilled at making the links between apparently disparate technologies and ideas to create real innovation. Those opportunities that score highly in our initial appraisal are crafted into exciting collaborative programmes, typically involving two or three parties. ITI LS provides funding to cover the development costs of delivering the programme, while our experienced programme managers provide coordination of all parties. ITI LS is also able to draw on the outstanding expertise and global networks of our Advisory Board, composed of influential individuals drawn from international business and academia.

Responses are invited from companies, agencies, institutes, academia and individuals. No geographical restrictions apply and ITI welcomes responses to this call from non-UK organisations. ITI is committed to helping our partners achieve success and ensuring the successful onward commercialisation of programme outputs.

For further details please go to www.itilifesciences.com/call, or contact ITI Life Sciences at the number below.

Notes to Editors

About ITI Life Sciences

ITI Life Sciences is a unique and entrepreneurial organisation contributing to Scotland's economical growth in life sciences; it aims to leverage Scotland's research excellence to develop new technologies targeting future market needs.

Publicly funded, but commercially driven, ITI Life Sciences funds and manages early stage technology research and development programmes in the life sciences arena. It selects programmes based on assessing future market needs, identifying technology opportunities, and responding to ideas, initiatives and proposals from the research and business communities. ITI Life Sciences works in collaboration with partners from industry, academia and the financial community.

ITI Life Sciences is one of three Intermediary Technology Institutes (ITIs) focused on important areas where Scotland has strong economic and business potential; the other areas are Techmedia and Energy.

阅读本文的人还阅读:

当前生命科学发展的几个

【文摘发布】登革病毒调

【medical-news】肺癌化疗抵

三大因素影响我国今年医

我的第一篇综述:创伤骨

作者:admin@医学,生命科学    2011-07-27 05:37
医学,生命科学网